South Korea's drug safety agency on Wednesday approved the vaccine for the novel coronavirus by AstraZeneca for all adults, including those aged 65 and older, amid efficacy controversies, Yonhap News Agency reported.

A South Korean panel of experts has advised that vaccines for the novel coronavirus by AstraZeneca should be administered to people aged 65 or older following further discussion, according to the country's drug safety agency Friday.

The Indian government will provide 20 lakh doses of Oxford-Astrazenca Covid-19 vaccines (Covishield) to Bangladesh as a ‘gift’ on January 21.